Biblio

Found 30 results
Author Keyword Title Type [ Year(Asc)]
Filters: Author is Jonathan A Ledermann  [Clear All Filters]
2014
A. Okamoto, Glasspool, R. M., Mabuchi, S., Matsumura, N., Nomura, H., Itamochi, H., Takano, M., Takano, T., Susumu, N., Aoki, D., Konishi, I., Covens, A., Ledermann, J. A., Mezzanzanica, D., Mezzazanica, D., Steer, C., Millan, D., McNeish, I. A., Pfisterer, J., Kang, S., Gladieff, L., Bryce, J., and Oza, A. M., Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S20-5, 2014.
J. A. Ledermann, Luvero, D., Shafer, A., O'Connor, D., Mangili, G., Friedlander, M. Leonard, Pfisterer, J., Mirza, M. R., Kim, J. - W., Alexandre, J., Oza, A. M., and Brown, J., Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S14-9, 2014.
P. Harter, Gershenson, D., Lhomme, C., Lecuru, F., Ledermann, J. A., Provencher, D. M., Mezzanzanica, D., Quinn, M., Maenpaa, J. U., Kim, J. - W., Mahner, S., Hilpert, F., Baumann, K. H., Pfisterer, J., and du Bois, A., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S5-8, 2014.
I. Ray-Coquard, Brown, J., Harter, P., Provencher, D. M., Fong, P. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. Berton, Glasspool, R. M., Mezzanzanica, D., and Colombo, N., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S42-7, 2014.
T. Satoh, Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J. A., Viswanathan, A., Mahner, S., Provencher, D. M., Mileshkin, L. R., Åvall-Lundqvist, E., Pautier, P., Reed, N. Simon, and Fujiwara, K., Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S102-8, 2014.
R. M. Glasspool, Martín, A. González, Millan, D., Lorusso, D., Åvall-Lundqvist, E., Hurteau, J. A., Davis, A., Hilpert, F., Kim, J. - W., Alexandre, J., and Ledermann, J. A., Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S26-9, 2014.
D. Berton-Rigaud, Devouassoux-Shisheboran, M., Ledermann, J. A., Leitao, M. M., Powell, M. A., Poveda, A. M., Beale, P., Glasspool, R. M., Creutzberg, C. L., Harter, P., Kim, J. - W., Reed, N. Simon, and Ray-Coquard, I., Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S55-60, 2014.
J. A. Ledermann and Ray-Coquard, I., Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges., Am Soc Clin Oncol Educ Book, pp. e282-6, 2014.
F. Collinson, Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M. K. B., Ledermann, J. A., Colombo, N., and Swart, A. Marie, Optimal treatment of early-stage ovarian cancer., Ann Oncol, vol. 25, no. 6, pp. 1165-71, 2014.
2011
G. C. E. Stuart, Kitchener, H. C., Bacon, M., du Bois, A., Friedlander, M. Leonard, Ledermann, J. A., Marth, C., Thigpen, T., and Trimble, E. L., 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference., Int J Gynecol Cancer, vol. 21, no. 4, pp. 750-5, 2011.
F. A. Raja, Griffin, C. L., Qian, W., Hirte, H., Parmar, M. K. B., Swart, A. Marie, and Ledermann, J. A., Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer., Br J Cancer, vol. 105, no. 7, pp. 884-9, 2011.
T. J. Perren, Swart, A. Marie, Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R., Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., and Oza, A. M., A phase 3 trial of bevacizumab in ovarian cancer., N Engl J Med, vol. 365, no. 26, p. 2496, 2011.
G. B. Kristensen, Perren, T. J., Qian, W., Pfisterer, J., Ledermann, J. A., Joly, F., Carey, M. S., Beale, P., Cervantes, A., and Oza, A. M., Result of interim analysis of overall survival in the phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. , J Clin Oncol , vol. 29, no. suppl; abstr LBA5006, 2011.
J. A. Ledermann, Marth, C., Carey, M. S., Birrer, M. J., Bowtell, D. D. L., Kaye, S. B., McNeish, I., Oza, A. M., Scambia, G., Rustin, G. J. S., Stehman, F. B., Gershenson, D., Thomas, G., Berns, E. M. J. J., Casado, A., Ottevanger, N., Hilpert, F., Kim, B. - G., Okamoto, A., Bacon, M., Kitchener, H. C., and Stuart, G. C. E., Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer., Int J Gynecol Cancer, vol. 21, no. 4, pp. 763-70, 2011.

Pages